NEW YORK, Oct. 17 – Deltagen has appointed Jeanne Y. Jew as vice president of business development, the company said on Wednesday. She was also made a member of the firm's executive management committee.

“We are actively looking at drug candidates internally and externally and I am confident Ms. Jew will provide tremendous value to our expanded business development efforts," said William Matthews, president and CEO of the genomic-based biotechnology company.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.